Abstract：Objective To evaluate the risk of cardiovascular disease in hypertensive patients managed by communities in Tongxiang in the next 10 years,and to provide evidence for the development of cardiovascular disease prevention strategies. Methods The information about hypertensive patients managed by communities was collected from Tongxiang resident health records management system. The risk of ischemic cardiovascular disease（ICVD）in the next 10 years was assessed by the Assessment Scale of 10-Year ICVD Risk in Chinese. Results A total of 27 173 hypertensive patients managed by communities with complete data were recruited,including 11 868 males,accounting for 43.68%,and 15 305 females,accounting for 56.32%. The median（inter-quartile range）of the total scores of 10-year ICVD risk in hypertensive patients was 8.00（3.00）,with 9.00（2.00）in males and 8.00（2.00）in females. The total scores of 10-year ICVD risk in males was significantly higher than those in females（P<0.05）. A total of 8 764 patients had high 10-year ICVD risk,accounting for 32.25%. The proportion of high10-year ICVD risk in females with hypertension was higher than that in males（P<0.05）. The weights of ICVD risk factors in males were 54.58% in age,17.42% in systolic blood pressure,14.27% in smoking,7.77% in body mass index,4.51% in total cholesterol and 1.45% in diabetes;the ones in females were 63.57% in age,14.63% in systolic blood pressure,9.81% in body mass index,6.00% in total cholesterol,5.88% in diabetes and 0.11% in smoking. Conclusion The ICVD risk of hypertensive patients managed by communities in Tongxiang is higher in the next 10 years. Male patients should focus on the control of blood pressure and smoking,while female patients should focus on the control of blood pressure and body weight.
ROTH G A,JOHNSON C,ABAJOBIR A,et al.Global,regional,and national burden of cardiovascular diseases for 10 causes,1990 to 2015[J]. Journal of the American College of Cardiology,2017,70(1):1-25.
World Health Organization. The challenge of cardiovascular disease-quick statistics,2016[EB/OL].(2016-10-10)[2018- 09-14]. http://www.euro.who.int/en/health-topics/noncommunicable-diseases/cardiovasculardiseases/ data-and-statistics.
GU D F,HE J,COXSON P G,et al.The cost-effectiveness oflow-cost essential antihypertensive medicines for hypertension control in China:a modelling study[J]. PLoS Medicine,2015, 12(8):e1001860.
